A comparative analysis of human adult testicular cells expressing stem Leydig cell markers in the interstitium, vasculature, and peritubular layer.
human testis
markers
propagation
stem Leydig cells
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
23
01
2020
revised:
30
04
2020
accepted:
08
05
2020
pubmed:
18
5
2020
medline:
10
8
2021
entrez:
17
5
2020
Statut:
ppublish
Résumé
Origin of human adult Leydig cells (ALCs) is not well understood. This might be partly due to limited data available on the identification and location of human precursor and stem Leydig cells (SLCs) which hampers the study on the development of ALCs. The aim of the present study was to investigate whether described human (PDGFRα, NGFR) and rodent (NES, PDGFRα, THY1, NR2F2) SLC markers are expressed by a common cell population within human adult testicular interstitial cells in vivo and before and after in vitro propagation. Immunohistochemical analyses were used to identify localization of human adult testicular interstitial cells expressing described SLC markers. Next, interstitial cells were isolated and cultured. The percentage of cells expressing one or more SLC markers was determined before and after culture using flow cytometry. NR2F2 and PDGFRα were present in peritubular, perivascular, and Leydig cells, while THY1 was expressed in peritubular and perivascular cells. Although NES and NGFR were expressed in endothelial cells, co-localization with PDGFRα was found for both in vitro, although for NGFR only after culture. All marker positive cells were able to undergo propagation in vitro. The partly overlap in localization and overlap in expression in human testicular cells indicate that PDGFRα, NR2F2, and THY1 are expressed within the same ALC developmental lineage from SLCs. Based on the in vitro results, this is also true for NES and after in vitro propagation for NGFR. Our results that earlier described SLC markers are expressed in overlapping human interstitial cell population opens up further research strategies aiming for a better insight in the Leydig cell lineage and will be helpful for development of strategies to cure ALC dysfunction.
Sections du résumé
BACKGROUND
Origin of human adult Leydig cells (ALCs) is not well understood. This might be partly due to limited data available on the identification and location of human precursor and stem Leydig cells (SLCs) which hampers the study on the development of ALCs.
OBJECTIVES
The aim of the present study was to investigate whether described human (PDGFRα, NGFR) and rodent (NES, PDGFRα, THY1, NR2F2) SLC markers are expressed by a common cell population within human adult testicular interstitial cells in vivo and before and after in vitro propagation.
MATERIALS AND METHODS
Immunohistochemical analyses were used to identify localization of human adult testicular interstitial cells expressing described SLC markers. Next, interstitial cells were isolated and cultured. The percentage of cells expressing one or more SLC markers was determined before and after culture using flow cytometry.
RESULTS
NR2F2 and PDGFRα were present in peritubular, perivascular, and Leydig cells, while THY1 was expressed in peritubular and perivascular cells. Although NES and NGFR were expressed in endothelial cells, co-localization with PDGFRα was found for both in vitro, although for NGFR only after culture. All marker positive cells were able to undergo propagation in vitro.
DISCUSSION
The partly overlap in localization and overlap in expression in human testicular cells indicate that PDGFRα, NR2F2, and THY1 are expressed within the same ALC developmental lineage from SLCs. Based on the in vitro results, this is also true for NES and after in vitro propagation for NGFR.
CONCLUSION
Our results that earlier described SLC markers are expressed in overlapping human interstitial cell population opens up further research strategies aiming for a better insight in the Leydig cell lineage and will be helpful for development of strategies to cure ALC dysfunction.
Identifiants
pubmed: 32416031
doi: 10.1111/andr.12817
pmc: PMC7496384
doi:
Substances chimiques
Biomarkers
0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1265-1276Informations de copyright
© 2020 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.
Références
Anat Rec. 1984 Jun;209(2):165-76
pubmed: 6465527
Cell Death Dis. 2017 Oct 12;8(10):e3123
pubmed: 29022899
Anat Rec. 1990 Dec;228(4):405-17
pubmed: 2178325
Cell Tissue Res. 2004 Jun;316(3):369-76
pubmed: 15127288
Stem Cells. 2017 May;35(5):1222-1232
pubmed: 28090714
J Anat. 1990 Oct;172:103-14
pubmed: 2272896
J Endocrinol. 2001 Feb;168(2):213-6
pubmed: 11182757
Mol Endocrinol. 2001 Jan;15(1):172-83
pubmed: 11145748
Andrology. 2020 Sep;8(5):1265-1276
pubmed: 32416031
Cell Stem Cell. 2020 Feb 6;26(2):262-276.e4
pubmed: 31928944
J Clin Endocrinol Metab. 1974 Apr;38(4):612-7
pubmed: 4856555
Hum Reprod. 2019 Sep 29;34(9):1621-1631
pubmed: 31398257
Andrologia. 1978 Nov-Dec;10(6):444-52
pubmed: 32801
Mol Cell Endocrinol. 2013 Jun 15;372(1-2):96-104
pubmed: 23545158
Proc Natl Acad Sci U S A. 2014 May 6;111(18):E1924-32
pubmed: 24753613
Physiol Rev. 2019 Apr 1;99(2):1281-1324
pubmed: 30864875
Development. 2018 Dec 5;145(23):
pubmed: 30518625
Results Probl Cell Differ. 2016;58:67-100
pubmed: 27300176
J Androl. 1988 Sep-Oct;9(5):343-51
pubmed: 2853150
J Clin Endocrinol Metab. 2006 May;91(5):1956-60
pubmed: 16478819
Mol Hum Reprod. 2014 Feb;20(2):155-67
pubmed: 24214658
J Cell Biol. 2004 Dec 6;167(5):935-44
pubmed: 15569711
J Clin Endocrinol Metab. 2014 Jul;99(7):E1227-35
pubmed: 24684461
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2666-71
pubmed: 26929346
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2719-24
pubmed: 16467141
Biol Reprod. 1996 Aug;55(2):439-44
pubmed: 8828852
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Cell Tissue Res. 1987 Aug;249(2):367-77
pubmed: 3040255
J Clin Endocrinol Metab. 2002 May;87(5):2310-9
pubmed: 11994382
Dev Biol. 2009 Feb 1;326(1):112-20
pubmed: 19041858
Cell Tissue Res. 1985;242(1):145-56
pubmed: 4042133
Endocrinology. 2012 Oct;153(10):5002-10
pubmed: 22865373
Cell Tissue Res. 1986;246(2):229-36
pubmed: 3779804
Hum Reprod Update. 2015 May-Jun;21(3):310-28
pubmed: 25724971
Biol Reprod. 1998 Feb;58(2):520-5
pubmed: 9475409
Cell Res. 2014 Dec;24(12):1466-85
pubmed: 25418539
Horm Res Paediatr. 2010;73(2):93-101
pubmed: 20190545
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7212-7
pubmed: 18480267
Ther Clin Risk Manag. 2009 Jun;5(3):427-48
pubmed: 19707253
BMC Med. 2013 Apr 18;11:108
pubmed: 23597181
J Cell Sci. 1992 Oct;103 ( Pt 2):521-9
pubmed: 1478952
Sci Rep. 2019 Oct 21;9(1):15052
pubmed: 31636313